Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications The CpG island methylator phenotype in colorectal cancer: progress and problems, Cell Oncol (Dordr). Biochim Biophys Acta, vol.341825, pp.155-17677, 2011. ,
Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repairdefective human tumor cell lines, Cancer Res, vol.57, pp.808-811, 1997. ,
Microsatellite instability in colorectal cancer Genetic prognostic and predictive markers in colorectal cancer, Gastroenterology. Nat Rev Cancer, vol.1389, pp.2073-2087489, 2009. ,
Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer, JNCI Journal of the National Cancer Institute, vol.104, issue.21, pp.1635-1646, 2012. ,
DOI : 10.1093/jnci/djs427
Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer, Cancer Res, vol.63, pp.5738-5744, 2003. ,
Clinical implications of microsatellite instability in sporadic colon cancers, Current Opinion in Oncology, vol.21, issue.4, pp.369-373, 2009. ,
DOI : 10.1097/CCO.0b013e32832c94bd
Mismatch repair deficient colorectal cancer in the era of personalized treatment, Nature Reviews Clinical Oncology, vol.24, issue.4, pp.197-208, 2010. ,
DOI : 10.1172/JCI19757
Microsatellite instability in colorectal cancer???the stable evidence, Nature Reviews Clinical Oncology, vol.3, issue.3, pp.153-162, 2010. ,
DOI : 10.1200/JCO.2007.14.8064
Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin, Annals of Oncology, vol.21, issue.4, pp.772-780, 2010. ,
DOI : 10.1093/annonc/mdp383
Colorectal cancer molecular biology moves into clinical practice, Gut, vol.60, issue.1, pp.116-129, 2011. ,
DOI : 10.1136/gut.2009.206250
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006043
Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy, Clinical Cancer Research, vol.17, issue.23, pp.7470-7478, 2011. ,
DOI : 10.1158/1078-0432.CCR-11-1048
Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cells ,
Frequent alteration of DNA damage signalling and repair pathways in human colorectal cancers with microsatellite instability, Oncogene, vol.1, issue.40, pp.5919-5926, 2007. ,
DOI : 10.1038/sj.onc.1210419
Identification of Candidate Oncogenes in Human Colorectal Cancers With Microsatellite Instability, Gastroenterology, vol.145, issue.3, pp.540-543, 2013. ,
DOI : 10.1053/j.gastro.2013.05.015
Roles for Mismatch Repair Factors in Regulating Genetic Recombination, Molecular and Cellular Biology, vol.20, issue.21, pp.7839-7844, 2000. ,
DOI : 10.1128/MCB.20.21.7839-7844.2000
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC86394/pdf
DNA Mismatch Repair and Genetic Instability, Annual Review of Genetics, vol.34, issue.1, pp.359-399, 2000. ,
DOI : 10.1146/annurev.genet.34.1.359
Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint, Cancer Res, vol.55, pp.3721-3725, 1995. ,
Involvement of the mismatch repair system in temozolomide-induced apoptosis, Mol Pharmacol, vol.54, pp.334-341, 1998. ,
Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation, Cancer Res, vol.58, pp.767-778, 1998. ,
Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents, Proceedings of the National Academy of Sciences, vol.4, issue.1, pp.10764-10769, 1999. ,
DOI : 10.1128/MCB.14.3.1815
Comparative lesion sequencing provides insights into tumor evolution, Proceedings of the National Academy of Sciences, vol.67, issue.24, pp.4283-4288, 2008. ,
DOI : 10.1158/0008-5472.CAN-07-1653
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2393770
A new animal model for human colon cancer metastasis, International Journal of Cancer, vol.4, issue.5, pp.625-630, 1987. ,
DOI : 10.1159/000408625
Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis, Cancer and Metastasis Review, vol.62, issue.3, pp.229-243, 1991. ,
DOI : 10.1038/bjc.1982.310
Early resection of primary orthotopicallygrowing human colon tumor in nude mouse prevents liver metastasis: further evidence for patient-like hematogenous metastatic route, Anticancer research, vol.13, pp.293-297, 1993. ,
Efficiency of orthotopic xenograft models for human colon cancers, In vivo, vol.10, pp.463-469, 1996. ,
An animal model for colon cancer metastasis: establishment and characterization of murine cell lines with enhanced liver-metastasizing ability, Cancer Res, vol.47, pp.1398-1406, 1987. ,
The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells, Cancer Res, vol.61, pp.6555-6562, 2001. ,
ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis, Gut, vol.61, issue.11, pp.1560-1567, 2012. ,
DOI : 10.1136/gutjnl-2011-301179
Independent Validation of a Prognostic Genomic Signature (ColoPrint) for Patients With Stage II Colon Cancer, Annals of Surgery, vol.257, issue.6, pp.1053-1058, 2013. ,
DOI : 10.1097/SLA.0b013e31827c1180
Genomic Classifier ColoPrint Predicts Recurrence in Stage II Colorectal Cancer Patients More Accurately Than Clinical Factors, The Oncologist, vol.20, issue.2, pp.127-133, 2015. ,
DOI : 10.1634/theoncologist.2014-0325
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319631
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer, Journal of Clinical Oncology, vol.29, issue.1, pp.17-24, 2011. ,
DOI : 10.1200/JCO.2010.30.1077
A molecular signature for the prediction of recurrence in colorectal cancer, Molecular Cancer, vol.14, issue.1, p.22, 2015. ,
DOI : 10.1002/ijc.22747
Specific genomic aberrations in primary colorectal cancer are associated with liver metastases, BMC Cancer, vol.6, issue.1, p.662, 2010. ,
DOI : 10.1016/j.cancergencyto.2005.12.011
Prediction of liver metastasis after ,
A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer, Cancer Discovery, vol.1, issue.6, pp.508-523, 2011. ,
DOI : 10.1158/2159-8290.CD-11-0109
Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer, Clinical Cancer Research, vol.18, issue.19, pp.5314-5328, 2012. ,
DOI : 10.1158/1078-0432.CCR-12-0372
Patient-derived tumour xenografts as models for oncology drug development, Nature Reviews Clinical Oncology, vol.14, issue.6, pp.338-350, 2012. ,
DOI : 10.1158/1078-0432.CCR-08-0509
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928688
Evaluating Patient-Derived Colorectal Cancer Xenografts as Preclinical Models by Comparison with Patient Clinical Data, Cancer Research, vol.75, issue.8, pp.1560-1566, 2015. ,
DOI : 10.1158/0008-5472.CAN-14-1590
Signalling cell cycle arrest and cell death through the MMR System, Carcinogenesis, vol.27, issue.4, pp.682-692, 2006. ,
DOI : 10.1093/carcin/bgi298
Peritoneal carcinomatosis of colorectal cancer: novel clinical and molecular outcomes, The American Journal of Surgery, vol.213, issue.2, pp.377-387, 2017. ,
DOI : 10.1016/j.amjsurg.2016.03.008
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis, Journal of Clinical Oncology, vol.23, issue.3, pp.609-618, 2005. ,
DOI : 10.1200/JCO.2005.01.086
Molecular predictors of survival after ,